eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
4/2024
vol. 75
 
Share:
Send email
Share:
Original paper

LncRNA-PVT1 enhances glucose metabolism of pediatric low-grade glioma cells through sponging miR-187-3p

Beibei Li
1
,
Zijian Feng
1
,
Yanyan Zheng
1

  1. Department of Neonatology, Weifang Maternal and Child Health Hospital, China
Pol J Pathol 2024; 75 (4): 324-332
DOI: https://doi.org/10.5114/pjp.2024.146455
Online publish date: 2024/12/30
Article file
- LncRNA-PVT1.pdf  [0.59 MB]
Get citation
 
PlumX metrics:
 
1. Ryall S, Tabori U, Hawkins C. Pediatric low-grade glioma in the era of molecular diagnostics. Acta Neuropathol Commun 2020; 8: 30. DOI: 10.1186/s40478-020-00902-z.
2. Bale TA, Rosenblum MK. The 2021 WHO Classification of Tumors of the Central Nervous System: an update on pediatric low-grade gliomas and glioneuronal tumors. Brain Pathol 2022; 32: e13060. DOI: 10.1111/bpa.13060.
3. Pérez JPM, Muchart J, López VS, et al. Targeted therapy for pediatric low-grade glioma. Childs Nerv Syst 2021; 37: 2511-2520.
4. Fangusaro J, Bandopadhayay P. The “Risk” in Pediatric Low-Grade Glioma. Cancer Cell 2020; 37: 424-425.
5. Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 2021; 22: 96-118.
6. Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer 2021; 21: 22-36.
7. Tan YT, Lin JF, Li T, et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond) 2021; 41: 109-120.
8. Chen PY, Li XD, Ma WN, et al. Comprehensive transcriptomic analysis and experimental validation identify lncRNA HOXA-AS2/miR-184/COL6A2 as the critical ceRNA regulation involved in low-grade glioma recurrence. Onco Targets Ther 2020; 13: 4999-5016.
9. Xu S, Tang L, Liu Z, ET AL. Hypoxia-related lncRNA correlates with prognosis and immune microenvironment in lower- grade glioma. Front Immunol 2021; 12: 731048. DOI: 10.3389/ fimmu.2021.731048
10. Lu D, Luo P, Wang Q, et al. lncRNA PVT1 in cancer: a review and meta-analysis. Clin Chim Acta 2017; 474: 1-7.
11. Zhou C, Yi C, Yi Y, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer 2020; 19: 118. DOI: 10.1186/s12943-020-01237-y.
12. Chen J, Yu Y, Li H, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer 2019; 18: 33. DOI: 10.1186/s12943-019-0947-9.
13. Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab 2022; 34: 355-377.
14. Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov 2022; 21: 141-162.
15. Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325-337.
16. Ghanavat M, Shahrouzian M, Deris Zayeri Z, et al. Digging deeper through glucose metabolism and its regulators in cancer and metastasis. Life Sci 2021; 264: 118603. DOI: 10.1016/j.lfs. 2020.118603.
17. Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA- ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 2014; 42 (Database issue): D92-D97. DOI: 10.1093/nar/gkt1248.
18. Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of microRNA expression in cancer. Int J Mol Sci 2020; 21: 1723. DOI: 10.3390/ijms21051723.
19. Wang L, Cho KB, Li Y, et al. Long noncoding RNA (lncRNA)- mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci 2019; 20: 5758. DOI: 10.3390/ijms20225758.
20. Wu Y, Tao L, Liang J, et al. miR-187-3p increases gemcitabine sensitivity in breast cancer cells by targeting FGF9 expression. Exp Ther Med 2020; 20: 952-960.
21. Geng J, Yang K. circCCND1 regulates oxidative stress and FGF9 to Enhance chemoresistance of non-small cell lung cancer via sponging miR-187-3p. DNA Cell Biol 2021; 40: 675-682.
Copyright: © 2024 Polish Association of Pathologists and the Polish Branch of the International Academy of Pathology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.